Type 2 Diabetes: News

• Breastfeeding: USPSTF Finds Poor Support in Primary Care A lack of primary care support, compounded by socioeconomic barriers, can interfere with a family’s desire to breastfeed a child.
  Medscape Medical News, April 11, 2025
• Malnutrition-Related Diabetes Officially Named ‘Type 5’ The new name and endorsement at the World Diabetes Congress are seen as long overdue recognition that will spur more research.
  Medscape Medical News, April 11, 2025
• ATTD 2025 GLP-1s Eyed as Key to Managing T1D With Obesity As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are increasingly viewed as adjuncts to insulin.
  Medscape Medical News, April 11, 2025
• More Evidence Ties Diabetes Meds to Lower Dementia Risk GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a neuroprotective effect.
  Medscape Medical News, April 08, 2025
• Study Strengthens Link Between Maternal Diabetes and Autism A large new study adds to evidence that diabetes during pregnancy is linked with an increased risk of brain and nervous system problems in children, including autism,...
  Reuters Health Information, April 07, 2025
• Primary Care Practices See Steady Rise in Diabetes Cases As diabetes cases soar in the US, physicians are sounding the alarm, especially in economically challenged regions. The push for intensive screening and proactive management has never been more critical.
  Medscape Medical News, April 07, 2025
• When Should You Refer a Patient With Diabetes to an Endo? Primary care doctors can treat most patients with diabetes, but occasionally, you may want to call in a specialist. Here’s how to decide.
  Medscape Medical News, April 07, 2025
• USCAP 2025 Noninvasive Tests Unreliable in Assessing Liver Fibrosis Major discrepancies are seen with the use of noninvasive tests compared with liver biopsy in a posttransplant setting.
  Medscape Medical News, April 07, 2025
• What Else Can GLP-1 Drugs Do for Your Patients? How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, and neurological diseases.
  Medscape Medical News, April 07, 2025
• ACP-IM 2025 Switching to Tirzepatide Outweighs Upping Dulaglutide Dose The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.
  Medscape Medical News, April 04, 2025
• ATTD 2025 How Close Is Fully Closed-Loop Automated Insulin Delivery? At the recent ATTD 2025 meeting, participants discussed recent progress and remaining challenges in developing a fully closed-loop automated insulin delivery system.
  Medscape Medical News, April 04, 2025
• Obesity ‘Strongly’ Linked to 16 Cardiometabolic Diseases The prevalence of metabolic dysfunction–associated steatotic liver disease, chronic kidney disease, and obstructive sleep apnea, among others, increases with increasing BMI.
  Medscape Medical News, April 02, 2025
• ATTD 2025 Continuous Glucose Monitoring: For Insulin Users and Beyond Discussions at the Advanced Technologies & Treatments for Diabetes meeting covered CGM use in non–insulin-treated people with type 2 diabetes, in prediabetes, and for diabetes diagnosis.
  Medscape Medical News, March 31, 2025
• ACC 2025 Oral GLP-1 Receptor Agonist Reduces CV Risk Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established atherosclerotic disease, CKD, or both.
  Medscape Medical News, March 30, 2025
• ACC 2025 Semaglutide Shows Major Benefits in PAD: STRIDE The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a practice-changing trial, according to experts.
  Medscape Medical News, March 30, 2025
• ACC 2025 New Smartwatch Metric Points to Overall Heart Health A Northwestern medical student has found a better way of measuring heart health by smartwatch using a formula of steps per day and heart rate data.
  Medscape Medical News, March 29, 2025
• Clinical Trials Are Fleeing Europe: What Needs to Change? Bureaucracy and delays are pushing clinical trials away from Europe, with Asia and the United States taking the lead.
  Medscape Medical News, March 28, 2025
• Diabetes Prevention Program Cancellation a ‘Colossal Waste’ The recent federal cancellation of a 30-year-old study over a nonrelated dispute with the study coordinator, Columbia University, leaves investigators ‘reeling.’
  Medscape Medical News, March 26, 2025
• Top Chronic Diseases Every Med Student Should Know By the time you graduate medical school, you should have a handle on these chronic diseases, as you’ll likely encounter them at some point in your career.
  Medscape Medical News, March 25, 2025
• ATTD 2025 Should ‘Time in Tight Range’ Be the Primary Diabetes Goal? At the annual ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.
  Medscape Medical News, March 25, 2025